Heart failure in systemic right ventricle: Mechanisms and therapeutic options

d-loop transposition of the great arteries (d-TGA) and congenitally corrected transposition of the great arteries (cc-TGA) feature a right ventricle attempting to sustain the systemic circulation. A systemic right ventricle (sRV) cannot support cardiac output in the long run, eventually decompensati...

Full description

Bibliographic Details
Main Authors: Belal Nedal Sabbah, Tarek Ziad Arabi, Areez Shafqat, Saleha Abdul Rab, Adhil Razak, Dimpna Calila Albert-Brotons
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1064196/full
_version_ 1797956484136435712
author Belal Nedal Sabbah
Tarek Ziad Arabi
Areez Shafqat
Saleha Abdul Rab
Adhil Razak
Dimpna Calila Albert-Brotons
author_facet Belal Nedal Sabbah
Tarek Ziad Arabi
Areez Shafqat
Saleha Abdul Rab
Adhil Razak
Dimpna Calila Albert-Brotons
author_sort Belal Nedal Sabbah
collection DOAJ
description d-loop transposition of the great arteries (d-TGA) and congenitally corrected transposition of the great arteries (cc-TGA) feature a right ventricle attempting to sustain the systemic circulation. A systemic right ventricle (sRV) cannot support cardiac output in the long run, eventually decompensating and causing heart failure. The burden of d-TGA patients with previous atrial switch repair and cc-TGA patients with heart failure will only increase in the coming years due to the aging adult congenital heart disease population and improvements in the management of advanced heart failure. Clinical data still lags behind in developing evidence-based guidelines for risk stratification and management of sRV patients, and clinical trials for heart failure in these patients are underrepresented. Recent studies have provided foundational data for the commencement of robust clinical trials in d-TGA and cc-TGA patients. Further insights into the multifactorial nature of sRV failure can only be provided by the results of such studies. This review discusses the mechanisms of heart failure in sRV patients with biventricular circulation and how these mediators may be targeted clinically to alleviate sRV failure.
first_indexed 2024-04-10T23:50:42Z
format Article
id doaj.art-e075fffaf30c4adc8161c3393a2208e3
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T23:50:42Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-e075fffaf30c4adc8161c3393a2208e32023-01-10T20:02:26ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-01-01910.3389/fcvm.2022.10641961064196Heart failure in systemic right ventricle: Mechanisms and therapeutic optionsBelal Nedal Sabbah0Tarek Ziad Arabi1Areez Shafqat2Saleha Abdul Rab3Adhil Razak4Dimpna Calila Albert-Brotons5College of Medicine, Alfaisal University, Riyadh, Saudi ArabiaCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaDepartment of Pediatric Cardiology, Pediatric Heart Failure and Heart Transplant, Heart Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabiad-loop transposition of the great arteries (d-TGA) and congenitally corrected transposition of the great arteries (cc-TGA) feature a right ventricle attempting to sustain the systemic circulation. A systemic right ventricle (sRV) cannot support cardiac output in the long run, eventually decompensating and causing heart failure. The burden of d-TGA patients with previous atrial switch repair and cc-TGA patients with heart failure will only increase in the coming years due to the aging adult congenital heart disease population and improvements in the management of advanced heart failure. Clinical data still lags behind in developing evidence-based guidelines for risk stratification and management of sRV patients, and clinical trials for heart failure in these patients are underrepresented. Recent studies have provided foundational data for the commencement of robust clinical trials in d-TGA and cc-TGA patients. Further insights into the multifactorial nature of sRV failure can only be provided by the results of such studies. This review discusses the mechanisms of heart failure in sRV patients with biventricular circulation and how these mediators may be targeted clinically to alleviate sRV failure.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1064196/fullsystemic right ventricleheart failuredextro-transposition of the great arteriescongenitally corrected transposition of the great arteriesatrial switch repairtricuspid regurgitation
spellingShingle Belal Nedal Sabbah
Tarek Ziad Arabi
Areez Shafqat
Saleha Abdul Rab
Adhil Razak
Dimpna Calila Albert-Brotons
Heart failure in systemic right ventricle: Mechanisms and therapeutic options
Frontiers in Cardiovascular Medicine
systemic right ventricle
heart failure
dextro-transposition of the great arteries
congenitally corrected transposition of the great arteries
atrial switch repair
tricuspid regurgitation
title Heart failure in systemic right ventricle: Mechanisms and therapeutic options
title_full Heart failure in systemic right ventricle: Mechanisms and therapeutic options
title_fullStr Heart failure in systemic right ventricle: Mechanisms and therapeutic options
title_full_unstemmed Heart failure in systemic right ventricle: Mechanisms and therapeutic options
title_short Heart failure in systemic right ventricle: Mechanisms and therapeutic options
title_sort heart failure in systemic right ventricle mechanisms and therapeutic options
topic systemic right ventricle
heart failure
dextro-transposition of the great arteries
congenitally corrected transposition of the great arteries
atrial switch repair
tricuspid regurgitation
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1064196/full
work_keys_str_mv AT belalnedalsabbah heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions
AT tarekziadarabi heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions
AT areezshafqat heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions
AT salehaabdulrab heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions
AT adhilrazak heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions
AT dimpnacalilaalbertbrotons heartfailureinsystemicrightventriclemechanismsandtherapeuticoptions